Serum and Urine Biomarkers in COPD Exacerbations
COPD Exacerbation Study
Sponsor: Alpha-1 Foundation
Enrolling: Male and Female Patients
IRB Number: AAAR3691
U.S. Govt. ID: NCT03823443
Contact: Laura Fonseca: 212-305-3745 /
Additional Study Information: We are asking you to participate in a research study to determine if we can detect changes in enzymes in the blood that may influence lung function decline in COPD (chronic obstructive pulmonary disease), in particular after COPD exacerbations. The procedures of the study include a pulmonary function test (breathing test), a short questionnaire, and blood and urine samples. The duration of the study is two years: first visit, followed by a second visit two years later. If you were to experience a COPD exacerbation (increased cough, sputum, shortness of breath requiring oral or IV steroids and/or antibiotics), we ask that you contact us for repeat blood draws and urine sample within three days of illness and again 30 days later. In addition, if not done in the clinical setting, a nasal swab will be performed to test for viral respiratory infections. For each completed visit (first visit, second visit two years later, and any intermediate visits), we will compensate $100 allocated in a Visa gift card. For more detailed information please contact Laura, Clinical Research Coordinator.
This study is closed
Monica Goldklang, MD
Do You Qualify?
Are you between 35 and 80 years of age? Yes No
Do you have a diagnosis of Alpha-1 Antitrypsin Deficiency or have an Alpha-1 Carrier status? Yes No
Do you have a diagnosis of Chronic Obstructive Pulmonary Disease (COPD)? Yes No
If female, are you currently pregnant? Yes No
Have you had any recent pulmonary infections (e.g., pneumonia, bronchitis, COPD exacerbations) within the last 1 month? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Laura Fonseca